Created in 2012 (Australia), INTERCEPT own 154 sister brands and 4472 competing brands. INTERCEPT is owned by Ansell, listed on the stock exchange of Francfort The International Securities Identification Number (ISIN) of Ansell is AU000000ANN9. INTERCEPT belongs to the Medical Devices & Instruments business sector.
Investment simulator :
Portfolio valuation
Ansell
(INTERCEPT)
over 5 years*
EUR 13.70